Safety and immunogenicity of an investigational quadrivalent meningococcal CRM197 conjugate vaccine, MenACWY-CRM, compared with licensed vaccines in adults in Latin America
Authors:
- D. StamboulianDSD. Stamboulian
- P.M. DullPDP.M. Dull
- 1 October 2010
- journal article
- research article
- Published by Elsevier in International Journal of Infectious Diseases
- Vol. 14 (10) , e868-e875
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- High prevalence of Neisseria meningitidis hypervirulent lineages and emergence of W135:P1.5,2:ST-11 clone in Southern BrazilJournal of Infection, 2008
- Caracterización de aislamientos invasivos de S. pneumoniae, H. influenzae y N. meningitidis en América Latina y el Caribe: SIREVA II, 2000-2005Revista Panamericana de Salud Pública, 2008
- Serogroup Y Meningococcal Disease, ColombiaEmerging Infectious Diseases, 2008
- Meningitis Serogroup W135 Outbreak, Burkina Faso, 2002Emerging Infectious Diseases, 2007
- Epidemic meningitis, meningococcaemia, and Neisseria meningitidisThe Lancet, 2007
- Meningococcal Meningitis: Unprecedented Incidence of Serogroup X--Related Cases in 2006 in NigerClinical Infectious Diseases, 2007
- Invasive Meningococcal Disease in Adolescents and Young AdultsJAMA, 2001
- Effectiveness of a Mass Immunization Campaign Against Serogroup C Meningococcal Disease in QuebecJAMA, 2001
- Identification of Vaccine Candidates Against Serogroup B Meningococcus by Whole-Genome SequencingScience, 2000
- The Changing Epidemiology of Meningococcal Disease in the United States, 1992–1996The Journal of Infectious Diseases, 1999